Oramed Pharmaceuticals (ORMP) Stock: Buy, Sell, or Hold?
ORMP - Oramed Pharmaceuticals Inc.
$4.15
0.09 (2.22%)
▲
5d:
-0.48%
30d:
-11.7%
90d:
+3.23%
BUY
HIGH Confidence
Analysis Updated: Oct 20, 2026 12:00 AM ET
Earnings: Nov 12, 2026
21d
Get Alerted When ORMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ORMP shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ORMP shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ORMP is currently trading at $4.15, which is considered oversold relative to its 30-day fair value range of $4.24 to $4.72.
Technical Outlook: Technically, ORMP is in a uptrend. Immediate support is located at $3.89, while resistance sits at $4.45.
Market Sentiment: ORMP scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+68.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ORMP is in a uptrend. Immediate support is located at $3.89, while resistance sits at $4.45.
Market Sentiment: ORMP scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.00 (+68.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.24 -
$4.72
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (85/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 68.7% below Wall St target ($7.00)
- BULLISH: Bottoming setup score 85/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$4.24 -
$4.72
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.89
Resistance Level
$4.45
Current Trend
Uptrend
Technical data as of
Oct 20, 2026
Fundamental Context
Wall Street Target
$7.00
(+68.7%)
Revenue Growth (YoY)
-100.0%
Earnings Growth (YoY)
493.5%
Share & Embed Analysis
Last updated: October 21, 2026 12:21 AM ET
Data refreshes hourly during market hours. Next update: 1:21 AM
Data refreshes hourly during market hours. Next update: 1:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORMP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 60 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 69 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 59 HOLD |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 75 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 66 BUY |
